These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 11401958)
1. Characterization of Haemophilus ducreyi-specific T-cell lines from lesions of experimentally infected human subjects. Gelfanova V; Humphreys TL; Spinola SM Infect Immun; 2001 Jul; 69(7):4224-31. PubMed ID: 11401958 [TBL] [Abstract][Full Text] [Related]
2. Dysregulated immune profiles for skin and dendritic cells are associated with increased host susceptibility to Haemophilus ducreyi infection in human volunteers. Humphreys TL; Li L; Li X; Janowicz DM; Fortney KR; Zhao Q; Li W; McClintick J; Katz BP; Wilkes DS; Edenberg HJ; Spinola SM Infect Immun; 2007 Dec; 75(12):5686-97. PubMed ID: 17893130 [TBL] [Abstract][Full Text] [Related]
3. The immune response to Haemophilus ducreyi resembles a delayed-type hypersensitivity reaction throughout experimental infection of human subjects. Palmer KL; Schnizlein-Bick CT; Orazi A; John K; Chen CY; Hood AF; Spinola SM J Infect Dis; 1998 Dec; 178(6):1688-97. PubMed ID: 9815221 [TBL] [Abstract][Full Text] [Related]
4. In vitro stimulation of peripheral blood mononuclear cells (PBMC) from HIV- and HIV+ chancroid patients by Haemophilus ducreyi antigens. Van Laer L; Vingerhoets J; Vanham G; Kestens L; Bwayo J; Otido J; Piot P; Roggen E Clin Exp Immunol; 1995 Nov; 102(2):243-50. PubMed ID: 7586673 [TBL] [Abstract][Full Text] [Related]
5. Haemophilus ducreyi elicits a cutaneous infiltrate of CD4 cells during experimental human infection. Spinola SM; Orazi A; Arno JN; Fortney K; Kotylo P; Chen CY; Campagnari AA; Hood AF J Infect Dis; 1996 Feb; 173(2):394-402. PubMed ID: 8568301 [TBL] [Abstract][Full Text] [Related]
6. Experimental human infection with Haemophilus ducreyi. Spinola SM; Wild LM; Apicella MA; Gaspari AA; Campagnari AA J Infect Dis; 1994 May; 169(5):1146-50. PubMed ID: 8169411 [TBL] [Abstract][Full Text] [Related]
7. Immune cells are required for cutaneous ulceration in a swine model of chancroid. San Mateo LR; Toffer KL; Orndorff PE; Kawula TH Infect Immun; 1999 Sep; 67(9):4963-7. PubMed ID: 10456960 [TBL] [Abstract][Full Text] [Related]
9. Induction of protective immunity to Haemophilus ducreyi in the temperature-dependent rabbit model of experimental chancroid. Hansen EJ; Lumbley SR; Richardson JA; Purcell BK; Stevens MK; Cope LD; Datte J; Radolf JD J Immunol; 1994 Jan; 152(1):184-92. PubMed ID: 8254191 [TBL] [Abstract][Full Text] [Related]
10. The cytolethal distending toxin of Haemophilus ducreyi aggravates dermal lesions in a rabbit model of chancroid. Wising C; Mölne L; Jonsson IM; Ahlman K; Lagergård T Microbes Infect; 2005 May; 7(5-6):867-74. PubMed ID: 15876546 [TBL] [Abstract][Full Text] [Related]
11. Interactions of the Skin Pathogen Brothwell JA; Griesenauer B; Chen L; Spinola SM Front Immunol; 2020; 11():615402. PubMed ID: 33613541 [TBL] [Abstract][Full Text] [Related]
12. Clinical and in situ cellular responses to Haemophilus ducreyi in the presence or absence of HIV infection. King R; Choudhri SH; Nasio J; Gough J; Nagelkerke NJ; Plummer FA; Ndinya-Achola JO; Ronald AR Int J STD AIDS; 1998 Sep; 9(9):531-6. PubMed ID: 9764937 [TBL] [Abstract][Full Text] [Related]
13. Immunization with the Haemophilus ducreyi hemoglobin receptor HgbA protects against infection in the swine model of chancroid. Afonina G; Leduc I; Nepluev I; Jeter C; Routh P; Almond G; Orndorff PE; Hobbs M; Elkins C Infect Immun; 2006 Apr; 74(4):2224-32. PubMed ID: 16552053 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of humoral and cell-mediated inducible immunity to Haemophilus ducreyi in an animal model of chancroid. Desjardins M; Filion LG; Robertson S; Kobylinski L; Cameron DW Infect Immun; 1996 May; 64(5):1778-88. PubMed ID: 8613391 [TBL] [Abstract][Full Text] [Related]
16. Haemophilus ducreyi infection causes basal keratinocyte cytotoxicity and elicits a unique cytokine induction pattern in an In vitro human skin model. Hobbs MM; Paul TR; Wyrick PB; Kawula TH Infect Immun; 1998 Jun; 66(6):2914-21. PubMed ID: 9596767 [TBL] [Abstract][Full Text] [Related]
17. Evolution of the cutaneous immune response to experimental Haemophilus ducreyi infection and its relevance to HIV-1 acquisition. Humphreys TL; Schnizlein-Bick CT; Katz BP; Baldridge LA; Hood AF; Hromas RA; Spinola SM J Immunol; 2002 Dec; 169(11):6316-23. PubMed ID: 12444138 [TBL] [Abstract][Full Text] [Related]
18. Development of a rapid immunodiagnostic test for Haemophilus ducreyi. Patterson K; Olsen B; Thomas C; Norn D; Tam M; Elkins C J Clin Microbiol; 2002 Oct; 40(10):3694-702. PubMed ID: 12354868 [TBL] [Abstract][Full Text] [Related]
19. Mechanism of human natural killer cell activation by Haemophilus ducreyi. Li W; Janowicz DM; Fortney KR; Katz BP; Spinola SM J Infect Dis; 2009 Aug; 200(4):590-8. PubMed ID: 19572804 [TBL] [Abstract][Full Text] [Related]
20. Neutropenia restores virulence to an attenuated Cu,Zn superoxide dismutase-deficient Haemophilus ducreyi strain in the swine model of chancroid. San Mateo LR; Toffer KL; Orndorff PE; Kawula TH Infect Immun; 1999 Oct; 67(10):5345-51. PubMed ID: 10496915 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]